---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-23-001383"
form_type: "8-K"
ticker: "GTHP"
cik: "0000924515"
company_name: "GUIDED THERAPEUTICS INC"
filed_at: "2023-03-09T23:59:59+00:00"
generated_at: "2026-06-18T08:07:50.739379+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Guided Therapeutics CEO Gene Cartwright retires; Mark Faupel appointed as successor

## Summary
- Gene Cartwright retired as President, CEO, and Board member effective March 3, 2023; no disagreement cited.
- Board appointed COO Dr. Mark Faupel (Ph.D., 67) as President and CEO effective March 6, 2023; he was CEO from 2007-2013.
- Alan Grujic appointed to Board effective March 8, 2023; brings finance and hedge fund experience.
- Faupel's compensation as CEO to be determined later by compensation committee.
- Grujic is not appointed to any Board committees; no related-party transactions disclosed.

## SEC filing metadata
- accession: 0001477932-23-001383
- form_type: 8-K
- ticker: GTHP
- cik: 0000924515
- company_name: GUIDED THERAPEUTICS INC
- filed_at: 2023-03-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/924515/000147793223001383/0001477932-23-001383-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/924515/000147793223001383/gthp_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-23-001383
- JSON: https://secwatch.observer/filing/0001477932-23-001383.json
- Plain text: https://secwatch.observer/filing/0001477932-23-001383.txt

## Key facts
- Executive change
  Alan Grujic was appointed as Director at GUIDED THERAPEUTICS INC.
  - Action: appointed
  - Role: Director
  source text: the Board appointed Mr. Alan Grujic to replace Mr. Cartwright on the Board, effective March 8, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/924515/000147793223001383/0001477932-23-001383-index.htm
- Executive change
  Gene Cartwright retired as President and Chief Executive Officer at GUIDED THERAPEUTICS INC.
  - Action: retired
  - Role: President and Chief Executive Officer
  source text: Dr. Gene Cartwright notified the Board of Directors (the “ Board ”) of Guided Therapeutics, Inc. (the “ Company ”) of his intent to retire from his position as President and Chief Executive Officer of the Company and as a member of the Board, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/924515/000147793223001383/0001477932-23-001383-index.htm
- Executive change
  Mark Faupel was appointed as President and Chief Executive Officer at GUIDED THERAPEUTICS INC.
  - Action: appointed
  - Role: President and Chief Executive Officer
  source text: the Board appointed Dr. Mark Faupel, Ph.D., 67, the Company’s Chief Operating Officer since December 2016, to replace Mr. Cartwright as the Company’s President and Chief Executive Officer, effective as of March 6, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/924515/000147793223001383/0001477932-23-001383-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.